Group One Trading
LRMR icon

Group One Trading’s Larimar Therapeutics LRMR Stock Holding History

Group One Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.3K Buy
+16,300
New +$65.2K ﹤0.01% 4975
2025
Q4 		– Sell
-500
Closed -$1.61K – 8733
2025
Q3 		$1.61K Sell
500
-3,000
-86% -$11.2K ﹤0.01% 7960
2025
Q2 		$10.1K Buy
3,500
+1,300
+59% +$3.01K ﹤0.01% 6712
2025
Q1 		$4.73K Sell
2,200
-39,100
-95% -$124K ﹤0.01% 6672
2024
Q4 		$160K Sell
41,300
-5,500
-12% -$36.3K ﹤0.01% 4113
2024
Q3 		$307K Buy
+46,800
New +$376K ﹤0.01% 3245
2024
Q2 		– Sell
-37,600
Closed -$285K – 7160
2024
Q1 		$285K Buy
+37,600
New +$293K ﹤0.01% 3251
2023
Q3 		– Sell
-500
Closed -$1.56K – 8004
2023
Q2 		$1.56K Buy
+500
New +$2.04K ﹤0.01% 7161
2021
Q4 		– Sell
-1,000
Closed -$12K – 8571
2021
Q3 		$12K Hold
1,000
– – ﹤0.01% 7424
2021
Q2 		$10K Buy
+1,000
New +$11.3K ﹤0.01% 7519
2019
Q3 		– Sell
-367
Closed -$5K – 5369
2019
Q2 		$5K Hold
367
– – ﹤0.01% 4604
2019
Q1 		$12K Buy
+367
New +$18.8K ﹤0.01% 4209
2018
Q3 		– Sell
-1,067
Closed -$131K – 5419
2018
Q2 		$131K Sell
1,067
-50
-4% -$4.25K ﹤0.01% 3377
2018
Q1 		$100K Buy
1,117
+1,067
+2,134% +$90.4K ﹤0.01% 3240
2017
Q4 		$3K Sell
50
-117
-70% -$5.27K ﹤0.01% 4647
2017
Q3 		$7K Sell
167
-416
-71% -$17.3K ﹤0.01% 4389
2017
Q2 		$25K Buy
583
+166
+40% +$8.49K ﹤0.01% 3850
2017
Q1 		$23K Sell
417
-10,550
-96% -$524K ﹤0.01% 3817
2016
Q4 		$418K Sell
10,967
-416
-4% -$16.9K ﹤0.01% 1899
2016
Q3 		$452K Buy
11,383
+11,241
+7,916% +$511K ﹤0.01% 1895
2016
Q2 		$10K Sell
142
-1,500
-91% -$119K ﹤0.01% 4074
2016
Q1 		$132K Sell
1,642
-925
-36% -$73K ﹤0.01% 2627
2015
Q4 		$194K Buy
2,567
+1,475
+135% +$237K ﹤0.01% 2513
2015
Q3 		$419K Buy
+1,092
New +$492K 0.01% 1917

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Group One Trading's LRMR Position: Q4 2025 in Review

Group One Trading sold out of Larimar Therapeutics (LRMR) in Q4 2025, closing a stake of 133,701 shares — an estimated $520K sold.

Group One Trading first reported a position in LRMR in Q3 2015 and held it in 27 quarters. The position peaked at $432K in Q3 2025. 136 funds tracked by Wall St. Rank hold LRMR as of Q4 2025.

  • Group One Trading reported no remaining Larimar Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 133,701 Larimar Therapeutics shares in Q4 2025, an estimated $520K.
  • Group One Trading first reported a position in Larimar Therapeutics in Q3 2015 and held it in 27 quarters.
  • Group One Trading's Larimar Therapeutics position peaked at $432K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.